Delivery Order SPE2DB25D3201-SPE2DB25FNVTY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.44 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication in 4-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,188.66 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 gm). This firm fixed-price contract, with an ultimate completion date of August 19, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 mcg inhalation solution (4 gm) on July 22, 2025, with a ceiling value of $2,903.48. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The order is set for completion by July 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $4,865.00 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,926.08 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of Spiriva Respimat 2.5 mcg inhalation medication in support of military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVTYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,917.50 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling supply of a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Spiriva Respimat, a respiratory medication, exemplifies the company's role in fulfilling federal medical supply needs through the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/19/25 |